These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2866634)

  • 1. Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.
    Caccia S; Fong MH; Guiso G
    Xenobiotica; 1985 Oct; 15(10):835-44. PubMed ID: 2866634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.
    Caccia S; Conti I; Viganò G; Garattini S
    Pharmacology; 1986; 33(1):46-51. PubMed ID: 2874572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the rat.
    Caccia S; Muglia M; Mancinelli A; Garattini S
    Xenobiotica; 1983 Mar; 13(3):147-53. PubMed ID: 6613160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).
    Bianchi G; Caccia S; Della Vedova F; Garattini S
    Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyp2D6 catalyzes 5-hydroxylation of 1-(2-pyrimidinyl)-piperazine, an active metabolite of several psychoactive drugs, in human liver microsomes.
    Raghavan N; Zhang D; Zhu M; Zeng J; Christopher L
    Drug Metab Dispos; 2005 Feb; 33(2):203-8. PubMed ID: 15507542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
    Barrett JE; Witkin JM; Mansbach RS; Skolnick P; Weissman BA
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1009-13. PubMed ID: 2875168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vivo metabolism of 4-substituted arylpiperazines to pharmacologically active 1-arylpiperazines.
    Caccia S
    Boll Chim Farm; 1990 May; 129(5):183-9. PubMed ID: 1982054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
    Fuller RW; Perry KW
    J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine.
    Miller LG; Thompson ML; Byrnes JJ; Greenblatt DJ; Shemer A
    J Clin Psychopharmacol; 1992 Oct; 12(5):341-5. PubMed ID: 1362206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of interaction between cimetidine and buspirone.
    Gammans RE; Pfeffer M; Westrick ML; Faulkner HC; Rehm KD; Goodson PJ
    Pharmacotherapy; 1987; 7(3):72-9. PubMed ID: 2888096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of buspirone, BMY-13805 and 1-(2-pyrimidinyl)-piperazine on cat spinal reflexes.
    Matheson GK; Eison MS
    Methods Find Exp Clin Pharmacol; 1985 May; 7(5):231-8. PubMed ID: 2863439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of the anxiolytic agent buspirone with serotonin and other synaptic receptors in the human brain].
    Korneev AIa; Faktor MI; Chan TB
    Biull Eksp Biol Med; 1988 Jan; 105(1):41-3. PubMed ID: 2892547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons.
    Witkin JM; Mansbach RS; Barrett JE; Bolger GT; Skolnick P; Weissman B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):970-7. PubMed ID: 2891840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and quantitation of 1-(2-pyrimidinyl)piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brain.
    Caccia S; Garattini S; Mancinelli A; Muglia M
    J Chromatogr; 1982 Dec; 252():310-4. PubMed ID: 7182413
    [No Abstract]   [Full Text] [Related]  

  • 15. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.
    Geller I; Hartmann RJ
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):25-33. PubMed ID: 6130070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The central action of 1-(2-pyrimidinyl)-piperazine, an ipsapirone metabolite.
    Tatarczyńska E; Pawłowski L; Chojnacka-Wójcik E; Maj J
    Pol J Pharmacol Pharm; 1989; 41(1):51-61. PubMed ID: 2587437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
    Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.